DOI: 10.1055/s-00000019

Fortschritte der Neurologie · Psychiatrie

References

Hartter S, Koenen-Bergmann M, Sharma A. et al.
Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin.

British journal of clinical pharmacology 2012;
74: 490-500

Hartter S, Koenen-Bergmann M, Sharma A. et al.
Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin.

British journal of clinical pharmacology 2012;
74: 490-500

Download Bibliographical Data

Search in:
Access: